Heparin Ratiopharm (Heparin Sodium)

Q: What is the active ingredient in Heparin Ratiopharm?

Heparin Ratiopharm contains heparin sodium, which acts as an anticoagulant by enhancing antithrombin III activity.

Q: How is Heparin Ratiopharm administered?

The product is given by subcutaneous (cutaneous) injection, typically performed by a healthcare professional.

Q: For which conditions is Heparin Ratiopharm commonly used?

It is commonly used to prevent deep‑vein thrombosis, to reduce the risk of pulmonary embolism, and to treat established venous thromboembolism.

Q: Can Heparin Ratiopharm be used during dialysis?

Yes, it may be used to maintain catheter patency and provide anticoagulation during hemodialysis procedures.

Q: What monitoring is recommended while a patient receives Heparin Ratiopharm?

Monitoring of activated partial thromboplastin time (aPTT) or anti‑Xa activity is often recommended to ensure therapeutic anticoagulation.

Q: What are the most common side effects of Heparin Ratiopharm?

Common side effects include minor injection‑site bleeding, bruising, small hematomas, mild nausea, and transient liver‑enzyme elevations.

Q: What serious adverse reaction should be watched for with Heparin Ratiopharm?

Heparin‑induced thrombocytopenia (HIT) and major internal bleeding are serious reactions that require immediate medical attention.

Q: Is Heparin Ratiopharm safe for use in pregnancy?

Safety in pregnancy has not been fully established; it should only be used when the potential benefit outweighs the potential risk to the fetus.

Q: Which medications should be avoided while taking Heparin Ratiopharm?

Concurrent use of other anticoagulants, antiplatelet agents, and thrombolytic drugs should be avoided unless closely monitored.

Q: Can herbal supplements affect Heparin Ratiopharm therapy?

Herbal products such as ginkgo biloba, garlic, and ginger have mild antiplatelet effects and may increase bleeding risk when combined with heparin.

Heparin Ratiopharm is a medicinal product that contains the active ingredient heparin sodium. It is supplied in a cutaneous (subcutaneous) formulation, typical of injectable anticoagulants, and is marketed in the European Union. The preparation belongs to the anticoagulant drug class and is used under supervision to reduce the risk of blood clot formation. The product is intended for patients requiring anticoagulation therapy and should be administered by a healthcare professional.

Manufacturer / TM Owner

Ratiopharm Gmbh

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Heparin Ratiopharm is employed in clinical practice to prevent and treat thrombotic conditions where anticoagulation is indicated.

Prevention of deep‑vein thrombosis (DVT) in patients undergoing orthopedic or general surgery.
Prophylaxis of pulmonary embolism in high‑risk postoperative or immobilized patients.
Treatment of acute venous thromboembolism, including DVT and pulmonary embolism.
Maintenance of catheter or dialysis circuit patency.
Anticoagulation support during hemodialysis procedures.
Adjunct therapy in acute coronary syndrome when rapid anticoagulation is required.

Side Effects

Heparin Ratiopharm may be associated with a range of adverse reactions that vary in frequency and severity.

Common

Minor bleeding at the injection site or bruising.
Small hematomas or superficial skin hemorrhage.
Transient elevation of liver enzymes.
Mild nausea or vomiting.
Local irritation or redness at the injection area.

Serious

Major hemorrhage, including internal bleeding.
Heparin‑induced thrombocytopenia (HIT) with a rapid fall in platelet count.
Allergic reactions such as urticaria, angioedema, or anaphylaxis.

Precautions & Warnings

When prescribing Heparin Ratiopharm, clinicians should evaluate patient‑specific factors and monitor for potential complications.

Assess bleeding risk, including recent surgery, trauma, or active gastrointestinal bleeding.
Review patient history for heparin‑induced thrombocytopenia or hypersensitivity to heparin.
Adjust dose in patients with renal or hepatic impairment as recommended.
Monitor activated partial thromboplastin time (aPTT) or anti‑Xa levels where applicable.
Use caution in pregnant or lactating women; benefits must outweigh potential risks.
Avoid use in patients with known severe thrombocytopenia (<50,000/µL).

Avoid Interactions

Heparin Ratiopharm can interact with other agents that affect coagulation or platelet function.

Avoid

Concurrent use of other anticoagulants (e.g., warfarin, direct oral anticoagulants) without close monitoring.
Antiplatelet drugs such as aspirin, clopidogrel, or NSAIDs that increase bleeding risk.
Thrombolytic agents (e.g., alteplase, streptokinase) due to additive hemorrhagic potential.

Use with caution

Certain antibiotics (e.g., quinolones, vancomycin) that may potentiate anticoagulant effect.
High‑dose corticosteroids, which can alter platelet function.
Herbal supplements such as ginkgo biloba, garlic, or ginger that have mild antiplatelet activity.

Frequently Asked Questions